Matthew K. O’Shea

5.8k total citations
70 papers, 1.1k citations indexed

About

Matthew K. O’Shea is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Matthew K. O’Shea has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 26 papers in Epidemiology and 17 papers in Immunology. Recurrent topics in Matthew K. O’Shea's work include Tuberculosis Research and Epidemiology (26 papers), Mycobacterium research and diagnosis (11 papers) and Immune responses and vaccinations (8 papers). Matthew K. O’Shea is often cited by papers focused on Tuberculosis Research and Epidemiology (26 papers), Mycobacterium research and diagnosis (11 papers) and Immune responses and vaccinations (8 papers). Matthew K. O’Shea collaborates with scholars based in United Kingdom, United States and South Africa. Matthew K. O’Shea's co-authors include Helen McShane, Rachel Tanner, Helen A. Fletcher, Adam F. Cunningham, Gregory C. Gray, Martin Dedicoat, Stephanie A. Harris, Tom Fletcher, David Wilson and Iman Satti and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Matthew K. O’Shea

66 papers receiving 1.1k citations

Peers

Matthew K. O’Shea
Matthew K. O’Shea
Citations per year, relative to Matthew K. O’Shea Matthew K. O’Shea (= 1×) peers Olivier Épaulard

Countries citing papers authored by Matthew K. O’Shea

Since Specialization
Citations

This map shows the geographic impact of Matthew K. O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew K. O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew K. O’Shea more than expected).

Fields of papers citing papers by Matthew K. O’Shea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew K. O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew K. O’Shea. The network helps show where Matthew K. O’Shea may publish in the future.

Co-authorship network of co-authors of Matthew K. O’Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew K. O’Shea. A scholar is included among the top collaborators of Matthew K. O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew K. O’Shea. Matthew K. O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baharani, Jyoti, et al.. (2025). Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK. Clinical Kidney Journal. 18(7). sfaf197–sfaf197. 1 indexed citations
2.
Pallett, Scott J C, et al.. (2025). Previously treated latent tuberculosis infection is associated with less severe acute COVID-19: a cohort study. BMJ Open Respiratory Research. 12(1). e003003–e003003.
3.
Woolley, Stephen, Aula Abbara, Lucy Lamb, et al.. (2024). Conflict and catastrophe-related severe burn injuries: A challenging setting for antimicrobial decision-making. Journal of Infection. 89(3). 106224–106224. 1 indexed citations
4.
Cunningham, L., Jonathan W. D. Mason, Emily R. Adams, et al.. (2024). A comparative study of traditional and molecular diagnostic methods for detection of gastrointestinal parasites in Nepalese migrants to the UK. Journal of Infection. 89(6). 106324–106324.
5.
Pallett, Scott J C, Matthew Routledge, Christine Bennett, et al.. (2024). Prevalence of extended-spectrum β-lactamase-producing Enterobacterales and carbapenemase-resistant Enterobacterales in British military cohorts. BMJ Military Health. 172(1). 54–59. 1 indexed citations
6.
Pallett, Scott J C, Sara E. Boyd, Matthew K. O’Shea, et al.. (2023). The contribution of human conflict to the development of antimicrobial resistance. SHILAP Revista de lepidopterología. 3(1). 153–153. 29 indexed citations
7.
Woolley, Stephen, Robert Chambers, Jonathan Bishop, et al.. (2023). COVID-19 risk, attitudes and behaviour study (CRAB study): A knowledge, attitudes, and practise qualitative study of COVID-19 in the Royal Navy. Frontiers in Public Health. 10. 1101817–1101817. 3 indexed citations
8.
Bosworth, Andrew, et al.. (2023). Deployment of whole genome next-generation sequencing of SARS-CoV-2 in a military maritime setting. BMJ Military Health. 170(e2). e144–e149. 1 indexed citations
9.
Darby, Matthew, Adam F. Cunningham, Matthew K. O’Shea, et al.. (2023). Induction of Siglec-FhiCD101hi eosinophils in the lungs following murine hookworm Nippostrongylus brasiliensis infection. Frontiers in Immunology. 14. 1170807–1170807. 2 indexed citations
10.
Woolley, Stephen, Tom Fletcher, Matthew K. O’Shea, et al.. (2022). The 2022 monkeypox outbreak: A UK military perspective. Travel Medicine and Infectious Disease. 52. 102540–102540. 2 indexed citations
11.
Papakonstantinou, Danai, Steven Dunn, Simon J. Draper, et al.. (2021). Mapping Gene-by-Gene Single-Nucleotide Variation in 8,535 Mycobacterium tuberculosis Genomes: a Resource To Support Potential Vaccine and Drug Development. mSphere. 6(2). 3 indexed citations
12.
Tanner, Rachel, Iman Satti, Stephanie A. Harris, et al.. (2020). Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection. Frontiers in Immunology. 10. 2983–2983. 21 indexed citations
13.
Wilkie, Morven, Iman Satti, Alice Minhinnick, et al.. (2019). A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults. Vaccine. 38(4). 779–789. 63 indexed citations
14.
O’Shea, Matthew K., Darren G. Craig, Alastair Moore, et al.. (2016). A Health Care Worker with Ebola Virus Disease and Adverse Prognostic Factors Treated in Sierra Leone. American Journal of Tropical Medicine and Hygiene. 94(4). 829–832. 6 indexed citations
15.
Tanner, Rachel, Matthew K. O’Shea, Helen A. Fletcher, & Helen McShane. (2016). In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. Vaccine. 34(39). 4656–4665. 52 indexed citations
16.
Flaxman, Amy, Christine S. Rollier, Matthew K. O’Shea, et al.. (2016). Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion. Vaccine. 34(15). 1792–1799. 11 indexed citations
17.
O’Shea, Matthew K., Darren G. Craig, Raymond Kao, et al.. (2015). Diagnosis of Febrile Illnesses Other Than Ebola Virus Disease at an Ebola Treatment Unit in Sierra Leone: Table 1.. Clinical Infectious Diseases. 61(5). 795–798. 25 indexed citations
18.
O’Shea, Matthew K., et al.. (2014). Time-to-Detection in Culture Predicts Risk of Mycobacterium tuberculosis Transmission: A Cohort Study. Clinical Infectious Diseases. 59(2). 177–185. 20 indexed citations
19.
O’Shea, Matthew K., et al.. (2012). Lung Herniation after Cough-Induced Rupture of Intercostal Muscle. New England Journal of Medicine. 366(1). 74–74. 12 indexed citations
20.
O’Shea, Matthew K., et al.. (2009). Morbidity rates on Vanguard Class submarines during nuclear deterrent patrol: a retrospective review over 13 years.. PubMed. 95(3). 127–35. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026